rs121909223
Variant summary
Our verdict is Pathogenic. The variant received 27 ACMG points: 27P and 0B. PS1_Very_StrongPM1PM2PM5PP2PP3_StrongPP5_Very_Strong
The NM_000314.8(PTEN):c.370T>A(p.Cys124Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 13/22 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Likely pathogenic in ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. C124R) has been classified as Pathogenic.
Frequency
Consequence
NM_000314.8 missense
Scores
Clinical Significance
Conservation
Publications
- Cowden syndrome 1Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P
- PTEN hamartoma tumor syndromeInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- macrocephaly-autism syndromeInheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Genomics England PanelApp, Orphanet
- renal cell carcinomaInheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
- leiomyosarcomaInheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
- activated PI3K-delta syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Bannayan-Riley-Ruvalcaba syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Cowden diseaseInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Lhermitte-Duclos diseaseInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Proteus-like syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- glioma susceptibility 2Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 27 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| PTEN | NM_000314.8 | c.370T>A | p.Cys124Ser | missense_variant | Exon 5 of 9 | ENST00000371953.8 | NP_000305.3 | |
| PTEN | NM_001304717.5 | c.889T>A | p.Cys297Ser | missense_variant | Exon 6 of 10 | NP_001291646.4 | ||
| PTEN | NM_001304718.2 | c.-381T>A | 5_prime_UTR_variant | Exon 4 of 9 | NP_001291647.1 | 
Ensembl
Frequencies
GnomAD3 genomes  
GnomAD4 exome Cov.: 31 
GnomAD4 genome  
ClinVar
Submissions by phenotype
Cowden syndrome 1    Pathogenic:1 
- -
Hereditary cancer-predisposing syndrome    Pathogenic:1 
The p.C124S variant (also known as c.370T>A), located in coding exon 5 of the PTEN gene, results from a T to A substitution at nucleotide position 370. The cysteine at codon 124 is replaced by serine, an amino acid with dissimilar properties. This amino acid position is highly conserved in available vertebrate species. This same alteration, p.C124S, is also produced by a different nucleotide substitution at this codon, c.371G>C. The p.C124S (c.371G>C) alteration has been reported in multiple individuals with Cowden syndrome/Cowden-like syndrome (Tan MH et al. Am. J. Hum. Genet. 2011 Jan; 88(1):42-56; Rodríguez-Escudero I et al. Hum. Mol. Genet. 2011 Nov;20:4132-42; He X et al. J. Clin. Endocrinol. Metab. 2012 Nov;97:E2179-87). This alteration occurs in a catalytically active residue responsible for dephosphorylating the phospholipid second messenger phosphatidylinositol-3,4,5-trisphosphate (PIP3), which is critical for tumor suppressor function (Xiao Y et al. Cell. Signal. 2007 Jul; 19(7):1434-45; Chia JY et al. Biochim. Biophys. Acta. 2010 Sep; 1804(9):1785-95). Further, functional analysis have shown p.C124S results in ablation of the tumor suppressor activity of PTEN (Myers MP et al. Proc. Natl. Acad. Sci. U.S.A., 1998 Nov;95:13513-8; Rodríguez-Escudero I et al. Hum. Mol. Genet. 2011 Nov;20:4132-42). In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the majority of available evidence to date, this variant is likely to be pathogenic. -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at